Big Pharma Sells Ineffective, Potentially Deadly Anti-Cancer Drugs

November 15, 2014

5603674513_4b491438d1_o_slideshowMedical experts are by-word that the biggest flaw of Big Pharma today is a lofty percentage of ineffective products being sold exclusively of previous clinical trials. This is individually true when anti-cancer medications are concerned. The doleful fact is that Big Pharma prefers to besiege in advertising and bribing officials in place of attempting to make their products accurately effective. Today pharmaceutical manufacturing is handsomely funded by politicians and organized crime, since it’s has be appropriate to one of the most efficient cash laundering schemes that has already corrupted a of great size number ofUS and EU officials.

Biotech expert C. Glenn Begley, the author Vice-President and Global Head of Hematology and Oncology Research at Amgen – any of the largest cancer research centers in the US, is at this moment a senior vice president in aprivate biotech troop TetraLogic. In his article published in the Nature magazine back in March 2012, Glennstated that a line of tests conducted under his supervision proved that abroad of 53 anti-cancer drugs that had beendeveloped by “respected laboratories,” a whole of 47 showed no noticeable improvements in patients’ hale condition conditions (which amounts to 88%).

Unfortunately, this study was proven ~ful by a number of research teams, that got uniform results while running tests. In 2009, a clump of researchers at Michigan State University reached a homogeneous conclusion, just like Bayer‘sresearch team. At the identical time certain researchers, like the distinguished Harvard Medical School prefer to falsifiy their studies to have a hefty grant of 15 a thousand thousand dollars from the Federal government.

Big Parma is the whole of about PR campaigns and advertisement, though putting new potentially dangerous drugs forward the market. For example, Glivec and Sutent, that are authorized as far as concerns usage in Europe, are reducing the volume of tumoursby wiping out pericytes that prevent the growth of tumour-nourishing consanguinity vessels. As a result, supplementary testingsshowed, these drugs force cancer to scatter faster across a body, making it increasingly greater amount of deadly.

Canadian Professor at the Department of Pharmacology at Dalhousie University, George S. Robertson is moreover stressing the innefectivness of certain drugs that are vital principle put on the market today.

Over the more than two decades, the most promising drugs that should have allowed the people to fight cancer effectively were Gleevec and Herceptin. However, considered in the state of it has been recently discovered, cropped land of these medications initiated genetic mutations of cells, by turning a regular one into a malignant cell.

Scientists from Bayer had little haphazard with their studies as well. In 2011, in a paper “Believe it or not”, Bayer admitted that researchers couldn’t ~ by heart the same results on clinical affliction on stage two of their testings. The commander of Target Discovery at Bayer Schering Pharma admitted that inquiry teams couldn’t replicate the initial results of most of Bayer’s studies, none matter how hard they tried. Out of 47 potential new anti-cancer drugs less than common-quarter got behind stage two. The ignominy that followed put an end to altogether of anti-cancer studies at Bayer thoroughly.

According to C. Glenn Begley, while the investigation Amgen Inc, consisting of approximately 100 scientists could not confirm the official results of clinical trials, they contacted the producers of these drugs. Some of themdemanded that Amgen Inc should sign a non-disclosure agreement that should endure the facts from being published.

In pursuit of founded on grants Big Pharma is falsifying researches, through paying for factless publications in scientific journals, which must open a advancing eastward path to the introduction of novel drugs on the market, unconcerned of their potential danger. Unfortunatelly, the usual people across the globe are to pay conducive to this deceit, more often than not by their own lives.

WITNESS Blog is some ongoing conversation about the effective use of video in human rights campaigns to create policy, behavior, or practice changes.

Search keywords

Both comments and pings are currently closed.